Brainstorm Cell Therapeutics Inc. (BCLI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Brainstorm Cell Therapeut...

    NASDAQ: BCLI · Real-Time Price · USD
    0.75
    0.03 (4.17%)
    At close: Oct 03, 2025, 1:47 PM
    0.75
    0.00%
    After-hours: Oct 03, 2025, 01:47 PM EDT

    Brainstorm Cell Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 187K 1.3M 772K 18.86M
    Short-Term Investments
    		 n/a n/a 2.21M 3.24M
    Long-Term Investments
    		 184K 185K n/a n/a
    Other Long-Term Assets
    		 22K 22K 22.99K 26.98K
    Receivables
    		 63K 51K 91K 86K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 135K 23K n/a 14K
    Total Current Assets
    		 385K 1.9M 3.11M 23.28M
    Property-Plant & Equipment
    		 1.24M 2.1M 5.32M 5.97M
    Goodwill & Intangibles
    		 n/a 3K 9.00 17.00
    Total Long-Term Assets
    		 1.45M 2.31M 5.34M 6M
    Total Assets
    		 1.83M 4.21M 8.45M 29.28M
    Account Payables
    		 6.08M 4.95M 6.22M 3.7M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a 1.46M
    Other Current Liabilities
    		 2.35M 2.24M 1.06M -388K
    Total Current Liabilities
    		 8.98M 7.8M 8.8M 6.32M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 447K 594K n/a n/a
    Total Long-Term Liabilities
    		 618K 1.27M 2.67M 3.62M
    Total Liabilities
    		 9.6M 9.07M 11.47M 9.94M
    Total Debt
    		 720K 672K 4.09M 5.08M
    Book Value
    		 -7.76M -4.86M -3.02M 19.34M
    Book Value Per Share
    		 -1.46 -1.27 -1.23 7.98
    Common Stock
    		 14K 13K 12K 12K
    Retained Earnings
    		 -226.64M -215.01M -197.82M -173.54M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 -7.76M -4.86M -3.02M 19.34M
    Total Investments
    		 184K 185K 2.21M 3.24M

    Add to Watchlist